Log in to save to my catalogue

Cuproptosis related lncRNA signature as a prognostic and therapeutic biomarker in osteosarcoma immun...

Cuproptosis related lncRNA signature as a prognostic and therapeutic biomarker in osteosarcoma immun...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c78519c4ddf9499598df610214430204

Cuproptosis related lncRNA signature as a prognostic and therapeutic biomarker in osteosarcoma immunity

About this item

Full title

Cuproptosis related lncRNA signature as a prognostic and therapeutic biomarker in osteosarcoma immunity

Author / Creator

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2025-01, Vol.15 (1), p.221-16, Article 221

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Osteosarcoma is one of the most common malignant bone tumours in children. In this study, we aimed to construct a cuproptosis-related lncRNAs signature to predict the prognosis and immune landscape of osteosarcoma patients. Databases from TARGET were used to acquire osteosarcoma patient datasets, which included clinical information and RNA sequenci...

Alternative Titles

Full title

Cuproptosis related lncRNA signature as a prognostic and therapeutic biomarker in osteosarcoma immunity

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c78519c4ddf9499598df610214430204

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c78519c4ddf9499598df610214430204

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-024-84024-9

How to access this item